Between 2013 and 2023, the opacifying preparation for X-ray, diagnostic reagents market size value per capita in Sweden decreased consistently from $8.34 to $3.37. This represents a year-on-year percentage decrease, with more rapid declines occurring in the early years, particularly in 2014 and continuously reducing afterward. Over the last two years (2021-2023), the annual decline averaged 9.5%. From 2018 to 2023, the compound annual growth rate (CAGR) was -6.96%, highlighting a sustained downward trend.
Future trends to watch for include potential stabilization or uptick in demand driven by technological advancements in diagnostic imaging and healthcare initiatives, as well as economic factors affecting per capita healthcare expenditure in Sweden.
| # | 24 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 South Korea | 9.87 | 2023 | View data | ||
| 2 | 2 Italy | 9.66 | 2023 | View data | ||
| 3 | 3 Greece | 8.33 | 2023 | View data | ||
| 4 | 4 Australia | 7.28 | 2023 | View data | ||
| 5 | 5 Austria | 6.83 | 2023 | View data | ||
| 14 | 14 Uruguay | 3.8 | 2023 | View data | ||
| 15 | 15 New Zealand | 3.56 | 2023 | View data | ||
| 16 | 16 Sweden | 3.37 | 2023 | |||
| 17 | 17 Portugal | 3.31 | 2023 | View data | ||
| 18 | 18 Poland | 2.69 | 2023 | View data | ||
